Der and Bryant Lab Member Presents

Graduate student and Der and Bryant lab member, Jonathan DeLiberty presents on Friday, March 25th at noon. This presentation, part of the UNC Pharmacology Graduate Student Research Seminar Series, will be on Characterization of autophagy inhibition as a therapeutic strategy for pancreatic ductal adenocarcinoma. Best of luck, Jonathan!

Der Lab Wears Purple for Pancreatic Cancer

The labs of Der, Cox, Bryant, Pylayeva-Gupta and Yeh gathered outside of the Mary Ellen Jones building on Thursday, November 18th for the National Day of Pancreatic Cancer Awareness, part of the larger Pancreatic Cancer Awareness Month. The Der/Cox/Bryant supergroup dresses in purple all month long to promote awareness of the topic. Thank you for … Continue reading Der Lab Wears Purple for Pancreatic Cancer

Der Named Computational Medicine Program 2020 Pilot Award Winner

The UNC Computational Medicine Program sought collaborative proposals from research areas in Cognitive Computing/Machine Learning; Image Analysis/Computer Vision; Computational and Mathematical Modeling; Bioinformatics and Computational Genomics; Health Informatics and Network Analysis. Channing Der and Co-PI, Jeremy Purvis, won for “A topological model of the cell cycle in KRAS-driven cancers." You can read more about Dr. … Continue reading Der Named Computational Medicine Program 2020 Pilot Award Winner

Channing Der Interviewed by Science Magazine

Two new drugs finally hit ‘undruggable’ cancer target, providing hope for treatments By Jocelyn Kaiser Cancer researchers are making progress toward a goal that has eluded them for more than 30 years: shrinking tumors by shutting off a protein called KRAS that drives growth in many cancer types. A new type of drug aimed at KRAS … Continue reading Channing Der Interviewed by Science Magazine